Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 121

Results For "IP"

11174 News Found

Zota Health Care posts 83.86% revenue surge in FY26
Healthcare | May 25, 2026

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores


EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate
News | May 25, 2026

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings


EU regulator backs Allergan Aesthetics’ Boey in key step toward approval
Drug Approval | May 25, 2026

EU regulator backs Allergan Aesthetics’ Boey in key step toward approval

The decision marks a key step in the centralized EU review process


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy


AbbVie signals major oncology momentum at ASCO
R&D | May 25, 2026

AbbVie signals major oncology momentum at ASCO

With standout ADC and t-cell engager response data across hard-to-treat cancers


Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026
R&D | May 25, 2026

Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026

Highlights strong Vibegron results in older men & real-world prostate cancer insights


Enveric reports key safety milestone for EB-003 reinforcing clinical development path
Biotech | May 25, 2026

Enveric reports key safety milestone for EB-003 reinforcing clinical development path

The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
People | May 23, 2026

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.


Shreevar Kheruka appointed Managing Director at Borosil Limited
People | May 23, 2026

Shreevar Kheruka appointed Managing Director at Borosil Limited

Kheruka has played a key role in transforming Borosil into a diversified, international consumer-focused enterprise